Journal of Inflammation welcomes research submissions on all aspects of inflammation. Non-research articles are specially commissioned by the Editors-in-Chief.

Editors-in-Chief

  • Paul Kirkham, Imperial College London
  • Adriano Rossi, University of Edinburgh

Society affiliations

BIRASJournal of Inflammation is affiliated with the British Inflammation Research Association (BIRAs).

Articles

There has been an error retrieving the data. Please try again.

Editor's profile

Paul Kirkham

Paul Kirkham

Professor Paul Kirkham completed his first degree in Biochemistry at Leeds University in 1985 and went on to receive a PhD in Biochemistry from Surrey University. In 1989 he joined the Dept of Molecular and Cellular Immunology at the MRC National Institute for Medical Research as a postdoctoral fellow investigating mechanisms of B and T cell activation. Then in 1991, he moved to the BBSRC Institute for Animal Health to continue his research into molecular mechanisms regulating T cell activation and senescence. In 1998 he moved into industry and joined Novartis, where as a Lab Head in the Division of Immunology he led a team undertaking drug discovery research for respiratory disease. He returned to academia in 2008 following the award of a Royal Society Industry Fellowship and joined the staff at the National Heart and Lung Institute as a senior fellow within Imperial College London. Over the next 5 years he continued his research into the respiratory disease COPD and identified a novel mechanism that may explain the onset of lung destruction in COPD as well as discovering and patenting a biomarker to aid diagnosis and help patient stratification with this disease. In 2013 he moved to the University of Wolverhampton to take up a new post and in 2014 was made Professor of Cell biology within the School of Biomedical Sciences and a fellow of the HEA. His research interests focus on understanding the mechanisms of disease pathogenesis driven by oxidative stress and its impact on cell function and inflammation, particularly in relation to respiratory disease.

Adriano Rossi

Adriano G Rossi

Professor Rossi obtained a BSc (Hons) and PhD (under the supervision of Drs Euan MacIntyre and Rodger McMillan) in the Department of Pharmacology at the University of Glasgow. He then carried out postdoctoral research at Wake Forest University, Winston-Salem, North Carolina, USA in Professor Joseph O’Flaherty’s laboratory. When he returned to the UK he was awarded a Wellcome Trust Post-Doctoral grant that led to a lectureship in Professor Tim William’s department at the National Heart & Lung Institute, University of London. He subsequently joined Professor Chris Haslett’s Respiratory Medicine Unit at the University of Edinburgh as an MRC funded senior scientist. He currently holds a Personal Chair in Respiratory and Inflammation Pharmacology in the MRC Centre for Inflammation Research at the Queen’s Medical Research Institute at the University of Edinburgh. He was awarded a DSc from the University in 2010 and is a Fellow of the Society of Biology and a Fellow of the British Pharmacological Society.

His research involves investigating the cellular processes and signalling mechanisms controlling inflammation with a focus on understanding inflammation resolution especially the mechanisms regulating apoptosis and phagocyte recognition and phagocytosis of apoptotic cells. He has published over 180 articles in peer-reviewed journals, reviews and book chapters and has held several major research grants. He believes that his team will provide the scientific foundation for innovative approaches for the therapy of human inflammatory diseases.

Submit a manuscript Sign up for article alerts Contact us Support

Email updates

Receive periodic news and updates relating to this journal straight to your inbox.

Indexed by

  • BIOSIS
  • CABI
  • CAS
  • DOAJ
  • Embase
  • EmBiology
  • PubMed
  • PubMed Central
  • Science Citation Index Expanded
  • Scopus

View all

ISSN: 1476-9255